These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7327456)

  • 21. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
    Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
    Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psycopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)].
    Sukamoto T; Aikawa K; Itoh K; Nose T
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):447-68. PubMed ID: 7203280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
    Goto K; Osuga K; Haga K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G; Kühl UG; Rohte O
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacology of the new antiviral agent SK 1899.
    Ryu KH; Rhee HI; Jung I; Kim TS; Lee SJ; Im GJ; Lee N; Ryu DH; Kim YW; Kim JJ; Chang K; Lee BH; Shin HS; Kim EJ; Kim KH; Kim DK
    Arzneimittelforschung; 2000 Apr; 50(4):395-403. PubMed ID: 10800640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
    Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
    Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.
    Saito T; Fukuda T; Tajima S; Sukamoto T; Yamashita A; Kanazawa T; Morimoto Y; Shimohara K; Nishimura N; Yokota K
    Arzneimittelforschung; 1988 Feb; 38(2):267-72. PubMed ID: 2897196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Omori M; Muroda T; Nakajima S; Nakada Y; Tanada K; Senda N; Tanaka K; Makino H
    Jpn J Antibiot; 1980 Oct; 33(10):994-1018. PubMed ID: 6451724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
    Arisawa H; Fukui K; Imai E; Fujise N; Masunaga H
    Arzneimittelforschung; 2002; 52(4):225-32. PubMed ID: 12040964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological studies of antipsychotic drug, penfluridol. 2. General pharmacological properties].
    Ito K; Nurimoto S; Ochiai T; Horiuchi M; Suzuki S
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):501-17. PubMed ID: 1033105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.